Biblio
.
Gemcitabine resistance in non-small cell lung cancer is mediated through activation of the PI3K/AKT/NF-κB pathway and suppression of ERK signaling by reactive oxygen species. J Biochem Mol Toxicol. 2023:e23497.
Ligustrazine improves the compensative effect of Akt survival signaling to protect liver Kupffer cells in trauma-hemorrhagic shock rats. Chem Biol Drug Des. 2023.
Phosphorylation of Bcl-2 by JNK confers gemcitabine resistance in lung cancer cells by reducing autophagy-mediated cell death. Environ Toxicol. 2023.
Platelet-derived circulating soluble P-selectin is sufficient to induce hematopoietic stem cell mobilization. Stem Cell Res Ther. 2023;14(1):300.
. . . . . . . .
. . . . .
.
Identification of an HLA-B*35:01:01:01 variant, HLA-B*35:01:23, in a Taiwanese individual. HLA. 2020.
. .